Home » Gentium Says Therapy Promising in Treating, Preventing VOD
Gentium Says Therapy Promising in Treating, Preventing VOD
Italian Biopharma company Gentium S.p.A. said its Defibrotide therapy shows
a strong trend toward statistical significance in the prevention and treatment of Hepatic Veno-Occlusive Disease or VOD, a potentially life-threatening
condition that typically occurs as an important complication of stem cell transplantation.
RTTNews
RTTNews
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May